fr 66973 has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Miyayasu, K; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S | 1 |
| Masuda, K; Nakamura, T; Noda, K; Noguchi, H; Shibayama, F; Shimomura, K; Suzuki, A; Takagaki, S | 1 |
| Manda, T; Masuda, K; Matsumoto, S; Mizota, T; Mori, J; Mukumoto, S; Nakamura, T; Nishigaki, F; Oku, T; Shimomura, K | 1 |
3 other study(ies) available for fr 66973 and Experimental Neoplasms
| Article | Year |
|---|---|
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1998 |
A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Dealkylation; Dogs; Female; Half-Life; Humans; In Vitro Techniques; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Oxazines | 1989 |
Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Topics: Animals; Antineoplastic Agents; Blood Cells; Bone Marrow; Drug Resistance; Female; Hematopoietic Stem Cells; Humans; Leukemia P388; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Oxazines; Transplantation, Heterologous | 1988 |